Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [clinicaltrials:NCT00157079]
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [clinicaltrials:NCT00157079]
Bio2RDF identifier
NCT00157079
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00157079
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... y immunodeficiency disorders.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Efficacy Study of a ...... ary Immunodeficiency Disorders
completion date [clinicaltrials_vocabulary:completion-date]
2003-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-08T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Immune Thrombocytopenic Purpura (ITP)
Immunodeficiency
Kawasaki syndrome
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-06-26T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00157079
official title [clinicaltrials_vocabulary:official-title]
A Clinical Investigation to As ...... ary Immunodeficiency Disorders
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-06-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-10-01T00:00:00Z
identifier
clinicaltrials:NCT00157079
title
Safety and Efficacy Study of a ...... ary Immunodeficiency Disorders
@en
type
label
Safety and Efficacy Study of a ...... s [clinicaltrials:NCT00157079]
@en